quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:31:00·2044d
PRRelease
Aimmune Therapeutics, Inc. logo
GCI Liberty Inc. logo
Momenta Pharmaceuticals, Inc. logo
+1

ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm

AIMT· Aimmune Therapeutics, Inc.GLIBA· GCI Liberty Inc.MNTA· Momenta Pharmaceuticals, Inc.VAR· Varian Medical Systems, Inc.
Health CareTelecommunications
Full content unavailable. See the original source below.
Original source

Companies

  • AIMT
    Aimmune Therapeutics, Inc.
    Health Care
  • GLIBA
    GCI Liberty Inc.
    Telecommunications
  • MNTA
    Momenta Pharmaceuticals, Inc.
    Health Care
  • VAR
    Varian Medical Systems, Inc.
    Health Care

Recent analyst ratings

  • Feb 3GLIBAUpdateSeaport Research Partners$68.00

Related

  • PR1d
    GCI to Acquire Quintillion, Strengthening Alaska's Fiber Infrastructure
  • PR1d
    GCI to Acquire Quintillion, Strengthening Alaska's Fiber Infrastructure
  • PR3d
    Liberty Broadband Corporation to Conduct Quarterly Q&A Conference Call
  • PR3d
    GCI Liberty, Inc. Announces First Quarter Earnings Release and Conference Call
  • PR48d
    GCI Liberty, Inc. Announces 2026 Virtual Annual Meeting of Stockholders
  • PR49d
    Liberty Media Corporation Announces Transition of Renee Wilm to Senior Advisor
  • PR71d
    GCI Liberty Reports Fourth Quarter and Year End 2025 Financial and Operating Results
  • ANALYST79d
    Seaport Research Partners initiated coverage on GCI Liberty with a new price target
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022